Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001104659-16-162787

CEO bought 4,750 shares at an average $2.09 ($9,944)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WELCH WILLIAM J CEO 2016-12-16 Purchase +2,500 $2.10 $5,250 2,500 D: show line 1 in the form
WELCH WILLIAM J CEO 2016-12-16 Purchase +2,250 $2.09 $4,694 4,750 D: show line 2 in the form
Open-market purchases · 4,750 sh · avg $2.09 · $9,944
Loading xslF345X03/a4.xml…